Skip to main content
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL.
Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC.
Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1.
Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease.
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel.
Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children's Oncology Group report.
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis.
Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel.
Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy.